ArticleInternational journal of molecular sciences2024

Serum-Soluble CD163 Levels as a Prognostic Biomarker in Patients with Diffuse Large B-Cell Lymphoma Treated with Chemoimmunotherapy.

Aspasia Koudouna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.